Saroja Pharma Industries India Peer Comparison

Saroja Pharma Industries India Ltd. shows no current financial metrics, indicating a lack of operational performance or reporting issues. In contrast, its peers demonstrate varying degrees of growth, profitability, and valuation metrics, highlighting Saroja as a financially weak company compared to the sector.

• • Saroja Pharma has no reported financial performance metrics, making it difficult to assess its position against peers.
• • Sun Pharmaceutical Industries and Dr. Reddy's Laboratories emerge as strong performers with significant revenue growth and profitability metrics.
• • Cipla Ltd. and Mankind Pharma Ltd. show solid growth and appealing valuation metrics, suggesting potential value picks within the sector.

• • Sun Pharmaceutical Industries Ltd.: Strong revenue growth (8.42% YoY) and solid profitability metrics (ROE of 16.13%, Profit Margin of 20.85%).
• • Dr. Reddy's Laboratories Ltd.: High ROE (21.76%) and solid growth trajectory (16.54% YoY revenue growth) with attractive valuation (PE of 15.50).